Search research articles
Contact Us
Filters
Showing results (111-120 of 231) with videos related to
Page
of 24
Sort By:
Medical Physics
|
February 15, 2018
Technical Note: Error metrics for estimating the accuracy of needle/instrument placement during transperineal magnetic resonance/ultrasound-guided prostate interventions
Ester Bonmati, Yipeng Hu, Barbara Villarini, et al.
The Journal of Urology
|
July 24, 2020
Re: Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes?D. Deniffel, E. Salinas, M. Ientilucci, A. J. Evans, N. Fleshner, S. Ghai, R. Hamilton, A. Roberts, A. Toi, T. van der Kwast, A. Zlotta, A. Finelli, M. A. Haider and N. Perlis <i>J Urol</i> 2020; doi: 10.1097/JU.0000000000001157
Vasilis Stavrinides, Francesco Giganti, Shonit Punwani, et al.
Frontiers in Artificial Intelligence
|
December 6, 2021
The ReIMAGINE Multimodal Warehouse: Using Artificial Intelligence for Accurate Risk Stratification of Prostate Cancer
Aida Santaolalla, Tim Hulsen, Jenson Davis, et al.
BJU International
|
June 16, 2026
Artificial intelligence in urology: A review of United States Food and Drug Administration-cleared devices
Zhiyu Qian, Pietro Brin, Stephan Korn, et al.
European Urology Open Science
|
August 2, 2021
Which Prostate Cancers are Undetected by Multiparametric Magnetic Resonance Imaging in Men with Previous Prostate Biopsy? An Analysis from the PICTURE Study
Joseph M Norris, Lucy A M Simmons, Abi Kanthabalan, et al.
BJU International
|
September 14, 2013
TOOKAD(®) Soluble vascular-targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer
Abdel-Rahmène Azzouzi, Eric Barret, Caroline M Moore, et al.
The Journal of Urology
|
May 10, 2022
Geographic Variability, Time Trends and Association of Preoperative Magnetic Resonance Imaging with Surgical Outcomes for Elderly United States Men with Prostate Cancer: A Surveillance, Epidemiology, and End Results-Medicare Analysis
Alexander P Cole, Xi Chen, Bjoern J Langbein, et al.
Magnetic Resonance Imaging
|
January 4, 2020
DWI and PRECISE criteria in men on active surveillance for prostate cancer: A multicentre preliminary experience of different ADC calculations
Francesco Giganti, Martina Pecoraro, Davide Fierro, et al.
Plos One
|
February 3, 2022
A protocol for the VISION study: An indiVidual patient data meta-analysis of randomised trials comparing MRI-targeted biopsy to standard transrectal ultraSound guided bIopsy in the detection of prOstate cancer
Veeru Kasivisvanathan, Vinson Wai-Shun Chan, Keiran D Clement, et al.
Plos One
|
October 17, 2024
The RECONCILE study protocol: Exploiting image-based risk stratification in early prostate cancer to discriminate progressors from non-progressors (RECONCILE)
Teresa Marsden, Gerhardt Attard, Shonit Punwani, et al.
Page
of 24
Search research articles
Search
Showing results (111-120 of 231) with videos related to
Sort By:
Page
of 24
Medical Physics
|
February 15, 2018
Technical Note: Error metrics for estimating the accuracy of needle/instrument placement during transperineal magnetic resonance/ultrasound-guided prostate interventions
Ester Bonmati, Yipeng Hu, Barbara Villarini, et al.
The Journal of Urology
|
July 24, 2020
Re: Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes?D. Deniffel, E. Salinas, M. Ientilucci, A. J. Evans, N. Fleshner, S. Ghai, R. Hamilton, A. Roberts, A. Toi, T. van der Kwast, A. Zlotta, A. Finelli, M. A. Haider and N. Perlis <i>J Urol</i> 2020; doi: 10.1097/JU.0000000000001157
Vasilis Stavrinides, Francesco Giganti, Shonit Punwani, et al.
Frontiers in Artificial Intelligence
|
December 6, 2021
The ReIMAGINE Multimodal Warehouse: Using Artificial Intelligence for Accurate Risk Stratification of Prostate Cancer
Aida Santaolalla, Tim Hulsen, Jenson Davis, et al.
BJU International
|
June 16, 2026
Artificial intelligence in urology: A review of United States Food and Drug Administration-cleared devices
Zhiyu Qian, Pietro Brin, Stephan Korn, et al.
European Urology Open Science
|
August 2, 2021
Which Prostate Cancers are Undetected by Multiparametric Magnetic Resonance Imaging in Men with Previous Prostate Biopsy? An Analysis from the PICTURE Study
Joseph M Norris, Lucy A M Simmons, Abi Kanthabalan, et al.
BJU International
|
September 14, 2013
TOOKAD(®) Soluble vascular-targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer
Abdel-Rahmène Azzouzi, Eric Barret, Caroline M Moore, et al.
The Journal of Urology
|
May 10, 2022
Geographic Variability, Time Trends and Association of Preoperative Magnetic Resonance Imaging with Surgical Outcomes for Elderly United States Men with Prostate Cancer: A Surveillance, Epidemiology, and End Results-Medicare Analysis
Alexander P Cole, Xi Chen, Bjoern J Langbein, et al.
Magnetic Resonance Imaging
|
January 4, 2020
DWI and PRECISE criteria in men on active surveillance for prostate cancer: A multicentre preliminary experience of different ADC calculations
Francesco Giganti, Martina Pecoraro, Davide Fierro, et al.
Plos One
|
February 3, 2022
A protocol for the VISION study: An indiVidual patient data meta-analysis of randomised trials comparing MRI-targeted biopsy to standard transrectal ultraSound guided bIopsy in the detection of prOstate cancer
Veeru Kasivisvanathan, Vinson Wai-Shun Chan, Keiran D Clement, et al.
Plos One
|
October 17, 2024
The RECONCILE study protocol: Exploiting image-based risk stratification in early prostate cancer to discriminate progressors from non-progressors (RECONCILE)
Teresa Marsden, Gerhardt Attard, Shonit Punwani, et al.
Page
of 24